blood health Archives - Amazing Health Advances

Dark Chocolate & Tea Lower Blood Pressure as Effectively as Medication

The AHA! Team — Mon, 21 Jul 2025 05:34:36 +0000

Cassie B. via Natural News – Decades of research involving over 5,200 adults shows flavanol-rich foods like dark chocolate and tea can lower blood pressure as effectively as medications, without harmful side effects. A major meta-analysis found flavanol consumption reduces systolic blood pressure by 3 mmHg on average — and up to 6 mmHg for those with hypertension — matching prescription drug results. Flavanols boost nitric oxide, improving blood vessel function naturally, with only 0.4% of participants reporting mild, temporary discomfort, which is far safer than pharmaceutical side effects. Experts recommend 400 to 600 mg of flavanols daily, achievable through dark chocolate (70%+ cocoa), black tea, and apples, offering a cost-effective, drug-free health boost. Beyond blood pressure, flavanols enhance cognitive function, insulin sensitivity, and heart health, proving whole foods outperform synthetic drugs for long-term wellness. The medical establishment and Big Pharma have long pushed expensive, side-effect-laden drugs as the only solution for high blood pressure, a condition affecting nearly half of American adults. But groundbreaking research spanning 80 years and involving over 5,200 adults reveals a far safer, more natural alternative: flavanol-rich foods like dark chocolate, tea, apples, and grapes. These everyday delights don’t just slightly improve cardiovascular health; they rival the blood pressure-lowering effects of prescription medications, all without the risks of Big Pharma’s chemical concoctions. The comprehensive meta-analysis, published in the European Journal of Preventive Cardiology, examined 145 clinical trials and found that participants consuming flavanol-rich foods saw systolic blood pressure drop by an average of 3 mmHg and diastolic by 2 mmHg. For those with elevated blood pressure, the reductions were even more dramatic—up to 6 mmHg systolic and 3 mmHg diastolic, matching the impact of common hypertension drugs. The science behind nature’s medicine Flavanols, plant-based compounds abundant in cocoa and tea, work by boosting nitric oxide production, which relaxes blood vessels and improves circulation. Unlike synthetic pharmaceuticals, which often come with debilitating side effects, these natural compounds deliver benefits with near-zero risk. Only 0.4% of study participants reported mild, transient discomfort like headaches or digestive issues, which is a pretty big contrast to the dizziness, fatigue, and kidney strain linked to blood pressure medications. Findings are encouraging “The findings are encouraging for those looking for accessible ways to manage their blood pressure and support their heart health through enjoyable dietary changes,” said lead researcher Christian Heiss, a cardiovascular medicine professor at the University of Surrey. Translation: You don’t need a prescription to harness these benefits—just a trip to the grocery store. The implications are explosive. If millions of Americans swapped even a fraction of their blood pressure medications for daily dark chocolate or tea, the pharmaceutical industry would lose billions. No wonder corporate-controlled media and medical gatekeepers downplay these findings. How to harness flavanols without Big Food’s tricks Not all chocolate is created equal. Milk chocolate and alkalized cocoa (common in mass-produced brands) are stripped of flavanols. To reap the benefits, opt for minimally processed dark chocolate with at least 70% cocoa content or raw cocoa powder. Similarly, black tea outperforms green tea in flavanol content, delivering up to 269 mg per cup. Kristi Crowe-White, a nutrition professor at the University of Alabama, co-authored the first U.S. dietary guideline for flavanols, recommending 400-600 mg daily. this can easily achieved with: 2 cups of black tea (538 mg) 30 grams of dark chocolate (30 mg) 1 apple (12 mg) Compare that to the cost and side effects of a monthly prescription. Nature beats pharmaceuticals… again This isn’t just about blood pressure. Flavanols also enhance cognitive function, reduce insulin resistance, and improve endothelial health—benefits no single drug can claim. While the medical-industrial complex profits from keeping patients dependent, the truth is clear: real food, not lab-made chemicals, holds the key to lasting wellness. As always, the elites would rather you ignore this. But for those willing to think independently, the solution is as simple as a square of dark chocolate and a cup of tea. Your heart will thank you. Sources for this article include: TheEpochTimes.com StudyFinds.org SciTechDaily.com To read the original article, click here

The post Dark Chocolate & Tea Lower Blood Pressure as Effectively as Medication appeared first on Amazing Health Advances.

Cancers Can Be Detected in the Bloodstream Three Years Prior to Diagnosis

The AHA! Team — Fri, 20 Jun 2025 05:20:22 +0000

Johns Hopkins Medicine via Newswise – The study, partly funded by the National Institutes of Health, was published May 22 in Cancer Discovery. Genetic material shed by tumors can be detected in the bloodstream three years prior to cancer diagnosis, according to a study led by investigators at the Ludwig Center at Johns Hopkins, Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. The study, partly funded by the National Institutes of Health, was published May 22 in Cancer Discovery. Investigators were surprised they could detect cancer-derived mutations in the blood so much earlier, says lead study author Yuxuan Wang, M.D., Ph.D., an assistant professor of oncology at the Johns Hopkins University School of Medicine. “Three years earlier provides time for intervention. The tumors are likely to be much less advanced and more likely to be curable.” To determine how early cancers could be detected prior to clinical signs or symptoms, Wang and colleagues assessed plasma samples that were collected for the Atherosclerosis Risk in Communities (ARIC) study, a large National Institutes of Health-funded study to investigate risk factors for heart attack, stroke, heart failure and other cardiovascular diseases. They used highly accurate and sensitive sequencing techniques to analyze blood samples from 26 participants in the ARIC study who were diagnosed with cancer within six months after sample collection, and 26 from similar participants who were not diagnosed with cancer. At the time of blood sample collection, eight of these 52 participants scored positively on a multicancer early detection (MCED) laboratory test. All eight were diagnosed within four months following blood collection. For six of the eight individuals, investigators also were able to assess additional blood samples collected 3.1–3.5 years prior to diagnosis, and in four of these cases, tumor-derived mutations could also be identified in samples taken at the earlier timepoint. MCED tests “This study shows the promise of MCED tests in detecting cancers very early, and sets the benchmark sensitivities required for their success,” says Bert Vogelstein, M.D., Clayton Professor of Oncology, co-director of the Ludwig Center at Johns Hopkins and a senior author on the study. Detecting cancers years before their clinical diagnosis “Detecting cancers years before their clinical diagnosis could help provide management with a more favorable outcome,” adds Nickolas Papadopoulos, Ph.D., professor of oncology, Ludwig Center investigator and senior author of the study. “Of course, we need to determine the appropriate clinical follow-up after a positive test for such cancers.” The study was supported in part by National Institutes of Health grant #s R21NS113016, RA37CA230400, U01CA230691, P30 CA 06973, DRP 80057309, and U01 CA164975. Additional funding was provided by the Virginia and D.K. Ludwig Fund for Cancer Research, the Commonwealth Fund, the Thomas M Hohman Memorial Cancer Research Fund, The Sol Goldman Sequencing Facility at Johns Hopkins, The Conrad R. Hilton Foundation, the Benjamin Baker Endowment, Swim Across America, Burroughs Wellcome Career Award for Medical Scientists, Conquer Cancer – Fred J. Ansfield, MD, Endowed Young Investigator Award, and The V Foundation for Cancer Research. The Atherosclerosis Risk in Communities study has been funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract numbers 75N92022D00001, 75N92022D00002, 75N92022D00003, 75N92022D00004, and 75N92022D00005. To read the original article click here.

The post Cancers Can Be Detected in the Bloodstream Three Years Prior to Diagnosis appeared first on Amazing Health Advances.

Artificial Veins Could Boost Success of Organ Transplants

The AHA! Team — Fri, 14 Jun 2024 08:24:03 +0000

Zachy Hennessey via Israel21c – Bonus Biogroup has developed microscopic biodegradable tubes that run through an engineered transplant organ, supplying a steady flow of blood. Globally, there is a persistent shortage of viable organs for transplantation. This unmet need has spurred the development of “engineered organs” — cultivated tissue that mimics the structure and function of livers, hearts, lungs and other vital viscera. While these in-vitro inside parts can be used to fill the gap in organ supply, it’s really hard to supply blood throughout the newly transplanted tissue. To solve this problem, Bonus Biogroup, an Israeli biotechnology company specializing in next-generation tissue regeneration therapies, has developed a method of producing a sophisticated network of artificial blood vessels that will enable reliable blood flow to transplanted artificial organs, drastically increasing their viability. Tomer Bronshtein, VP of Business Development at Bonus Biogroup, elaborates on the issue it aims to resolve. “One of the biggest challenges in implementing engineered tissue is making sure that it is vascularized. If it isn’t, only the periphery of the tissue which is exposed to blood vessels will be nourished,” he tells ISRAEL21c. “Now, the body knows how to build blood vessels into new tissue, but this process takes time. After two or three days, if the new tissue is deprived of nutrients, these cells will die,” he says. “Even if the immune matching is superb — even if you could take it from your twin brother — if it’s not vascularized, it will not work.” You’re so vein Enter the Haifa-based company’s latest product: a network of microscopic biodegradable tubes that run throughout an engineered organ, acting as a “scaffold” that holds the cultivated cells together while supplying a steady flow of blood throughout the transplanted tissue. Thanks to its biodegradable qualities, the scaffold ensures the newly embedded organ gets a steady flow of blood until the body replaces the artificial veins with the real deal, at which point it decays and makes its way out of the system. The blood vessels are created through a process called “electrospinning,” which Bronshtein compares to the process of making cotton candy. “There you have sugar that is making fibers because of heat. In electrospinning, you have biomaterials that are making fibers as a result of an electric current,” he says. The cultivated vessels can be spun to customizable diameters ranging from single microns to tens of microns. The artificial bundle of veins hooks up to the body’s blood supply via a port bundled at one end, spreads throughout the transplanted organ, and comes together at the other end into another port hooked up to the body. Picture an apartment building that has one water main which then splits into pipes that run through every floor of the building, and then they all meet back up again to head into the sewer system. Bonus Biogroup made that plumbing system, but for in-vitro organs. Enough to grow around As of 2022, the engineered tissues market was valued at approximately $12 billion and is projected to grow at an annual rate of about 11%, reaching $33 billion by 2032. Bonus Biogroup is banking on its innovation helping this market reach even greater potential. The company’s bone grafting product, BonoFill, stands to serve around 6.2 million patients in the US alone. By utilizing accessible and cost-effective methods, the company can streamline production processes and make its technology more widely accessible, while maintaining its competitive edge through patent protection. The publicly-traded company, which employs 53 people, has obtained patent approvals in 17 European countries and England, safeguarding Bonus Therapeutics, its wholly-owned subsidiary, until 2036. To date, the company has raised $60 million, and it stands to serve around 6.2 million patients in the US alone with its bone grafting product, BonoFill. With that in mind, Bonus intends to grant access to its technology to anyone who wants to use it — so long as they go through the proper legal channels. “This technology is something that we have no intention to keep to ourselves. Once we have established the global patent coverage on this technology, we are able to extend its use to other potential users,” says Bronshtein. While the company is using its vascular network primarily for its prior products — engineered bone and soft tissue for transplantation — it could be used for other needs as well. “Our goal is to make it the first available choice to patients in any indication,” notes CEO Shai Meretzki. “We know that there are groups in the world trying to do what we’ve done and failing to do it. And we are willing to allow them to use the technology developed by us within their products.” “It’s like how only one company developed the Intel chip, but you can find that chip in many devices. It’s the same concept here. You can put our blood network inside a liver or kidney or pancreas or any other tissue. Because the market is so wide, we are willing to share it,” Meretzki says. “When we founded Bonus, we were looking for a real change. Our goal from scratch was to create blockbuster products that will treat millions in each indication. And I believe that’s exactly what we are doing.” To read the original article click here.

The post Artificial Veins Could Boost Success of Organ Transplants appeared first on Amazing Health Advances.

Powerful UPDATE: Improve Your Heart Function with These Simple Interventions

AHA Publisher — Tue, 16 Nov 2021 08:00:40 +0000

Edit Lang via NaturalHealth365 – [Lately it seems] we give little to no consideration to the number one killer of American people – heart disease. It is incomprehensible how a disease claiming the lives of 659,000 Americans every year gets no real attention from mainstream media and health authorities. But we are here to change that. In another captivating interview, we bring you real, practical health information that you can use to take charge of your heart health. You will not want to miss this conversation between Jonathan Landsman of NaturalHealth365 and Dr. Robert DeMaria, America’s Drugless Doctor. A Healthy Heart Starts with a Healthy Liver, Here Is Why Few people are aware of the intricate connection that exists between the heart and the liver. As Dr. Bob explains, blood flows up through the legs through the liver to the heart. Therefore, it’s critical to consider what we put in and on our bodies when working to improve heart health because it affects the liver’s health. When the liver is compromised, the blood flowing back to the heart will become impeded. Watch the video (above) to hear his explanation and find out what you can do to improve the health of your liver and cardiovascular system. What You Eat Can Impact Heart Function We have all heard the expression, “you are what you eat.” It turns out, what you eat also has a drastic effect on your heart. For instance, most people don’t know that sugar removes B vitamins from the body. Why does that matter? Because B vitamins are necessary to protect the integrity of heart valves. Scientists have confirmed this in a recent study that found people who ate a diet rich in B-vitamins are less likely to succumb to cardiovascular disease. Heart WARNING About Dehydration, Toxins in Our Food and the Environment Eating the wrong foods, exposure to environmental toxins, and chronic dehydration also exacerbate heart issues. Dehydration is particularly damaging, yet, most do not make the connection between lack of hydration and heart function. Dr. Bob gives a simple yet often overlooked explanation, revealing how inadequate hydration causes red blood cells to stick together, resulting in reduced oxygen levels, causing oxygen deprivation in the heart. Conversely, drinking more water causes the blood cells to separate, carrying more oxygen, increasing energy. Listen to Dr. Bob’s tip on how to stay on top of your hydration using an Oximeter. What’s the Bottom Line? If you want to improve your heart health, you have no other choice but to take charge of your health. Be proactive and take the time to understand how your bodily systems work. Ultimately, in the body, everything is interconnected. By nourishing your liver, removing environmental toxins, eliminating toxic foods, and maintaining optimum blood circulation, you will be well on your way to a heart-healthy you. Share this video with your friends and family to help empower them to embark on this journey with you. Sources used for this article: CDC.gov Rumble.com NIH.gov To read the original article click here.

The post Powerful UPDATE: Improve Your Heart Function with These Simple Interventions appeared first on Amazing Health Advances.